Is TELCON RF PHARMACEUTICAL. stock a buy?

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for TELCON RF PHARMACEUTICAL. 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was KRW5 220.00, you would have made a loss of KRW-4 606.00 per share or -88.24%

Yes, the average daily trading liquidity for TELCON RF PHARMACEUTICAL. is KRW216 624 thousand. You should therefore be able to get in and out of your positions relatively fast.

TELCON RF PHARMACEUTICAL. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.11, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for TELCON RF PHARMACEUTICAL. to be high [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.